Natixis Advisors, L.P. Novo Nordisk A S Transaction History
Natixis Advisors, L.P.
- $63 Billion
- Q2 2025
A detailed history of Natixis Advisors, L.P. transactions in Novo Nordisk A S stock. As of the latest transaction made, Natixis Advisors, L.P. holds 2,833,071 shares of NVO stock, worth $167 Million. This represents 0.31% of its overall portfolio holdings.
Number of Shares
2,833,071
Previous 2,914,104
2.78%
Holding current value
$167 Million
Previous $202 Million
3.37%
% of portfolio
0.31%
Previous 0.37%
Shares
32 transactions
Others Institutions Holding NVO
# of Institutions
1,747Shares Held
322MCall Options Held
13.7MPut Options Held
19.7M-
Jennison Associates LLC18.9MShares$1.11 Billion0.78% of portfolio
-
Bank Of America Corp Charlotte, NC14.7MShares$869 Million0.08% of portfolio
-
Morgan Stanley New York, NY14.3MShares$843 Million0.07% of portfolio
-
Loomis Sayles & CO L P12.6MShares$742 Million1.12% of portfolio
-
Capital International Investors Los Angeles, CA11.6MShares$686 Million0.14% of portfolio
About NOVO NORDISK A S
- Ticker NVO
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 2,257,289,984
- Market Cap $133B
- Description
- Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...